RH Revenue Outlook Disappoints But Investors Still Undervaluing Stock -- Market Talk

Dow Jones
2025/09/12

09:53 ET -- RH reducing its full-year outlook was disappointing given previous commentary from the company, but investors are still undervaluing the company's fundamentals, says Stifel analyst W. Andrew Carter, who cuts RH's price target to $320 from $390 but maintains a buy rating. The company is seeing traction internationally and reported a stronger second-quarter free cash flow. But Carter acknowledges uncertainty around tariffs may limit investor interest. Regarding tariffs, "we believe RH would be positioned as a winner long-term, but the headwinds/performance through this first wave has fallen short of the posturing offered on the 4Q24 earnings call," Carter says. (nicholas.miller@wsj.com)

 

(END) Dow Jones Newswires

September 12, 2025 09:53 ET (13:53 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10